Cargando…

The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer

Transformation to small cell lung cancer (SCLC) is one of the mechanisms of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). However, it is uncertain how it works and there is no standard treatment after the transformation. In this study, 7 patients with trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Haiyan, Liu, Li, Zhou, Chunhua, Xiong, Yi, Hu, Yijuan, Yang, Nong, Qu, Jingjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708892/ https://www.ncbi.nlm.nih.gov/pubmed/30896637 http://dx.doi.org/10.1097/MD.0000000000014893

Ejemplares similares

Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases
por: Ahn, Soomin, et al.
Publicado: (2016)

Newly developed anti-angiogenic therapy in non-small cell lung cancer
por: Qu, Jingjing, et al.
Publicado: (2017)

Clinicopathological features of patients with transformation from EGFR mutant lung adenocarcinoma to small cell lung cancer
por: Bai, Wenwen, et al.
Publicado: (2021)

A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance
por: Liu, Li, et al.
Publicado: (2021)

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy
por: Yu, Li, et al.
Publicado: (2022)

Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient
por: Hu, Yijuan, et al.
Publicado: (2019)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
por: Liu, Li, et al.
Publicado: (2021)

Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma
por: Sun, Fei, et al.
Publicado: (2018)

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer
por: Chen, Gong, et al.
Publicado: (2017)

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
por: Huang, Zhe, et al.
Publicado: (2022)

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature
por: Jiang, Shi-Yu, et al.
Publicado: (2016)

Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study
por: Zhang, Yongchang, et al.
Publicado: (2022)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
por: Zhou, Wensheng, et al.
Publicado: (2022)

Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy
por: Zhou, Yuling, et al.
Publicado: (2020)

A clinicopathologic analysis of microscopic extension in small cell lung cancer and lung adenocarcinoma: Determination of clinical target volume with precise radiotherapy
por: Gao, Liwei, et al.
Publicado: (2021)

Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases
por: Shen, Qian, et al.
Publicado: (2021)

Transformation of Two Cases of Lung Adenocarcinoma into Pulmonary Sarcomatoid Carcinoma following Treatment
por: Yang, Zhenyu, et al.
Publicado: (2021)

Ureteral metastasis of small cell lung cancer transformed from lung adenocarcinoma: A case report
por: Wang, Yi, et al.
Publicado: (2022)

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component
por: Li, Peng, et al.
Publicado: (2022)

Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma
por: Gow, Chien-Hung, et al.
Publicado: (2021)

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer
por: Zeng, Liang, et al.
Publicado: (2018)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma
por: Yu, Dong-Hu, et al.
Publicado: (2020)

Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism
por: Zhang, Yuan, et al.
Publicado: (2021)

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
por: Niederst, Matthew J., et al.
Publicado: (2015)

Small-cell transformation of ALK-rearranged non-small-cell adenocarcinoma of the lung
por: Balla, Agnes, et al.
Publicado: (2018)

Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers
por: Li, Jun, et al.
Publicado: (2022)

Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020)

Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
por: Chang, Jer-Hwa, et al.
Publicado: (2020)

Clinicopathological and prognostic significance of NCALD protein expression in lung adenocarcinoma
por: Chen, Yi, et al.
Publicado: (2019)

Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells
por: Chen, Zhenguang, et al.
Publicado: (2012)

Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report
por: Hong, Er, et al.
Publicado: (2022)

Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer
por: Huang, An, et al.
Publicado: (2021)

TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
por: Yang, Liu, et al.
Publicado: (2023)

Clinicopathological predictors of survival in resected primary lung adenocarcinoma
por: Jhala, Hiral, et al.
Publicado: (2022)

Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer
por: Xinli, Wang, et al.
Publicado: (2022)

Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature
por: Li, Dan, et al.
Publicado: (2018)

Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD)
por: Ma, Hongxia, et al.
Publicado: (2022)

Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma
por: Xu, Shi-Bin, et al.
Publicado: (2019)

Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery
por: Zhang, Suyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0c1m3rbdo8ojvqc9ghmbrvl9vn